Related Experiment Video
Updated: May 9, 2026
Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
Published on: August 19, 2025
Serum protein kinase Cα as a diagnostic biomarker of cancers
Jeong-Hun Kang1, Takeshi Mori, Hirotaro Kitazaki
1Department of Applied Chemistry, Faculty of Engineering, Kyushu University, Nishi-Ku, Fukuoka, Japan. jrjhkang@ncvc.go.jp
Background:
Several serum biomarkers such as antigens, soluble proteins, metabolites, and genes have been identified for the diagnosis of cancers and for monitoring the recurrence after cancer treatment.
Methods:
In the present study, a protein kinase C (PKC) α-specific peptide substrate was phosphorylated with serum samples collected from cancer-bearing mice (U87, A431, HepG2, and A549) and the phosphorylation ratio was detected by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS).
Results:
The phosphorylation ratio for peptide substrates significantly increased in the serum of cancer-bearing mice compared with the ratio found in control mice. The addition of a PKCα inhibitor induced a concentration-dependent decrease in phosphorylation ratios, but the non-PKCα inhibitors, rottlerin and H-89, did not significantly effect phosphorylation ratios.
Conclusions:
These results suggest that serum activated PKCα is a good biomarker applicable to cancer diagnosis.
